CLOVER HEALTH INVESTMENTS, CORP. /DE APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $9.29M, a 64.52% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $12.45M, a 52.90% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $26.11M, a 6.72% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $26.20M, a 6.11% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $104.38M, a 8.71% decline from fiscal 2024.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $114.33M, a 18.87% decline from fiscal 2023.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $140.93M, a 14.23% decline from fiscal 2022.
- CLOVER HEALTH INVESTMENTS, CORP. /DE apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $164.31M, a 0.36% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.29M 10-Q · filed 2026-08-07 | $21.74M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $12.45M 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $104.38M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $26.11M 10-Q · filed 2025-11-07 | $52.30M derived: sum of 2 quarters · filed 2026-08-07 | $78.74M derived: sum of 3 quarters · filed 2026-08-07 | |
| 2025-06-30 | $26.20M 10-Q · filed 2026-08-07 | $52.63M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $26.44M 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $114.33M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $27.99M 10-Q · filed 2025-11-07 | $55.89M derived: sum of 2 quarters · filed 2025-11-07 | $84.69M derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $27.90M 10-Q · filed 2025-11-07 | $56.70M derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | $28.80M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $140.93M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $33.07M 10-Q · filed 2024-11-08 | $69.18M derived: sum of 2 quarters · filed 2024-11-08 | $107.80M derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $36.11M 10-Q · filed 2024-11-08 | $74.72M derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-03-31 | $38.62M 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $164.31M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $42.64M 10-Q · filed 2023-11-06 | $84.57M derived: sum of 2 quarters · filed 2023-11-06 | $125.21M derived: sum of 3 quarters · filed 2023-11-06 | $156.39M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $41.93M 10-Q · filed 2023-11-06 | $82.57M derived: sum of 2 quarters · filed 2023-11-06 | $113.75M derived: sum of 3 quarters · filed 2024-03-14 | $160.55M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $40.64M 10-Q · filed 2023-11-06 | $71.82M derived: sum of 2 quarters · filed 2024-03-14 | $118.62M derived: sum of 3 quarters · filed 2024-03-14 | $161.65M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $31.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $77.98M derived: sum of 2 quarters · filed 2024-03-14 | $121.01M derived: sum of 3 quarters · filed 2024-03-14 | $163.72M 10-K · filed 2024-03-14 |
| 2021-09-30 | $46.80M 10-Q · filed 2022-11-07 | $89.83M derived: sum of 2 quarters · filed 2022-11-07 | $132.54M 10-Q · filed 2021-11-09 | $134.67M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $43.03M 10-Q · filed 2022-11-07 | $85.74M 10-Q · filed 2021-08-11 | $87.87M derived: sum of 3 quarters · filed 2023-03-01 | $89.37M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $42.71M 10-Q · filed 2022-11-07 | $44.84M derived: sum of 2 quarters · filed 2023-03-01 | $46.34M derived: sum of 3 quarters · filed 2023-03-01 | $47.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.63M derived: sum of 2 quarters · filed 2023-03-01 | $5.10M derived: sum of 3 quarters · filed 2023-03-01 | $7.08M 10-K · filed 2023-03-01 |
| 2020-09-30 | $1.50M 10-Q · filed 2021-11-09 | $2.97M derived: sum of 2 quarters · filed 2021-11-09 | $4.95M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.47M 10-Q · filed 2021-08-11 | $3.45M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $1.98M 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $3.30M 10-K · filed 2022-02-28 |